IRIS - Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi dell’Insubria.

IRInSubria - Institutional Repository Insubria
IRInSubria raccoglie, conserva, documenta e dissemina le informazioni sulla produzione scientifica dell'Università degli Studi dell’Insubria anche ai fini della valutazione della ricerca.

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 283
Titolo Data di pubblicazione Autore(i) File
Immunochemotherapy with rituximab, vincristine and 5-days cyclophosphamide (R-CV) for heavily pretreated follicular lymphoma 1-gen-2005 Lazzarino, M; Arcaini, L; Orlandi, E; Iacona, I; Bernasconi, P; Calatroni, S; Varettoni, M; Isa, L; Brusamolino, E; Bonfichi, M; Passamonti, Francesco; Burcheri, S; Pascutto, C; Regazzi, M.
Is life expectancy of polycythemia vera patients clearly different from that of the general population? 1-gen-2005 Kiladjian, Jean-Jacques; Bernard, Jean-Francois; Fenaux, Pierre; Passamonti, Francesco; Cazzola, Mario; Lazzarino, Mario; Morra, Enrica
PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia 1-gen-2005 Passamonti, Francesco; Pietra, D; Rumi, E; Arcaini, L; Della Porta, Mg; Malcovati, L; Pascutto, C; Lazzarino, M; Cazzola, M.
Exaggerated insect bite-like reaction in patients affected by oncohaematological diseases 1-gen-2005 Vassallo, C; Passamonti, Francesco; Cananzi, R; Brazzelli, V; Ardigò, M; Lazzarino, M; Borroni, G.
Pityriasis roseaelike eruption during treatment with imatinib mesylate: Description of 3 cases 1-gen-2005 Brazzelli, V; Prestinari, F; Roveda, E; Barbagallo, T; Bellani, E; Vassallo, C; Orlandi, E; Passamonti, Francesco; Borroni, G.
Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2 1-gen-2005 Kralovics, R; Teo, Ss; Buser, As; Brutsche, M; Tiedt, R; Tichelli, A; Passamonti, Francesco; Pietra, D; Cazzola, M; Skoda, Rc
A gain-of-function mutation of JAK2 in myeloproliferative disorders 1-gen-2005 Kralovics, R; Passamonti, Francesco; Buser, As; Teo, Ss; Tiedt, R; Passweg, Jr; Tichelli, A; Cazzola, M; Skoda, Rc
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making 1-gen-2005 Malcovati, L; Della Porta, Mg; Pascutto, C; Invernizzi, R; Boni, M; Travaglino, E; Passamonti, Francesco; Arcaini, L; Maffioli, M; Bernasconi, P; Lazzarino, M; Cazzola, M.
Leukemic transformation of polycythemia vera: a single center study of 23 patients 1-gen-2005 Passamonti, Francesco; Rumi, E; Arcaini, L; Castagnola, C; Lunghi, M; Bernasconi, P; Della Porta, Mg; Columbo, N; Pascutto, C; Cazzola, M; Lazzarino, M.
Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders 1-gen-2006 Passamonti, Francesco; Rumi, E; Pietra, D; Della Porta, Mg; Boveri, E; Pascutto, C; Vanelli, L; Arcaini, L; Burcheri, S; Malcovati, L; Lazzarino, M; Cazzola, M.
Chronic myeloproliferative diseases: Polycythemia, thrombocythemia, myelofibrosis - Preface 1-gen-2006 Lazzarino, Mario; Cazzola, Mario; Passamonti, Francesco
Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment 1-gen-2006 Arcaini, L; Colombo, N; Passamonti, Francesco; Burcheri, S; Orlandi, E; Brusamolino, E; Della Porta, M; Rumi, E; Montanari, F; Pascutto, C; Paulli, M; Lazzarino, M.
Role of the molecular staging and response in the management of follicular lymphoma patients 1-gen-2006 Arcaini, L; Colombo, N; Bernasconi, P; Calatroni, S; Passamonti, Francesco; Orlandi, E; Bonfichi, M; Burcheri, S; Della Porta, M; Rumi, E; Montanari, F; Algarotti, A; Pascutto, C; Lazzarino, M.
Not just clonal expansion of hematopoietic cells, but also activation of their progeny in the pathogenesis of myeloproliferative disorders 1-gen-2006 Cazzola, M; Passamonti, Francesco
Therapy of essential thrombocythemia 1-gen-2006 Passamonti, F.; Rumi, E.; Elena, C.; Cazzola, M.; Lazzarino, M.
Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up 1-gen-2006 Brusamolino, E; Baio, A; Orlandi, E; Arcaini, L; Passamonti, Francesco; Griva, V; Casagrande, W; Pascutto, C; Franchini, P; Lazzarino, M.
Dyspnea secondary to pulmonary hematopoiesis as presenting symptom of myelofibrosis with myeloid metaplasia 1-gen-2006 Rumi, E; Passamonti, Francesco; Boveri, E; De Amici, M; Astori, C; Braschi, M; Castagnola, C; Magrini, U; Cazzola, M; Lazzarino, M.
Nongastric marginal zone B-cell lymphoma of MALT: prognostic value of disease dissemination 1-gen-2006 Arcaini, L; Burcheri, S; Rossi, A; Passamonti, Francesco; Paulli, Marco; Boveri, E; Brusamolino, E; Orlandi, E; Molteni, A; Pulsoni, A; Cox, Mc; Orsucci, L; Fabbri, A; Frezzato, M; Voso, Mt; Zaja, F; Montanari, F; Pascutto, C; Morra, E; Cortelazzo, S; Lazzarino, M.
JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders 1-gen-2006 Rumi, E; Passamonti, Francesco; Pietra, D; Della Porta, Mg; Arcaini, L; Boggi, S; Elena, C; Boveri, E; Pascutto, C; Lazzarino, M; Cazzola, M.
Clinical value of the new biological data 1-gen-2006 Passamonti, F.; Rumi, E.; Elena, C.; Lazzarino, M.; Cazzola, M.
Mostrati risultati da 21 a 40 di 283
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile